Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,386 | 115,358 | 56,471 | 53,726 | 44,744 |
| Marketable Securities | 206,949 | 177,822 | 113,803 | 133,142 | 54,376 |
| TOTAL | $278,947 | $298,864 | $177,432 | $191,807 | $104,206 |
| Non-Current Assets | |||||
| PPE Net | 176 | 192 | 214 | 237 | 259 |
| Other Non-Current Assets | 549 | 1,557 | 1,663 | 584 | 690 |
| TOTAL | $725 | $1,749 | $1,877 | $821 | $949 |
| Total Assets | $279,672 | $300,613 | $179,309 | $192,628 | $105,155 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,632 | 2,285 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,529 | 3,508 | 3,836 | 1,832 | 8,998 |
| Accrued Expenses | 11,414 | 11,246 | 9,431 | 8,691 | 7,795 |
| TOTAL | $24,568 | $18,872 | $15,157 | $12,467 | $18,790 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,602 | 17,834 | 20,006 | 19,896 | 19,792 |
| Deferred Revenues | 1,517 | 1,517 | 1,517 | 1,517 | 1,517 |
| Other Non-Current Liabilities | 60 | 102 | 174 | 243 | 310 |
| TOTAL | $26,899 | $29,553 | $32,175 | $32,514 | $32,856 |
| Total Liabilities | $51,467 | $48,425 | $47,332 | $44,981 | $51,646 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,249 | 48,236 | 40,869 | 38,549 | 36,095 |
| Common Shares | 5 | 5 | 4 | 4 | 3 |
| Retained earnings | -596,351 | -568,628 | -548,205 | -527,768 | -510,706 |
| Other shareholders' equity | 9 | -4 | 53 | 117 | 48 |
| TOTAL | $228,205 | $252,188 | $131,977 | $147,647 | $53,509 |
| Total Liabilities And Equity | $279,672 | $300,613 | $179,309 | $192,628 | $105,155 |